NovAseptic, based in Gothenburg, Sweden, provides a range of products for aseptic processing applications in biotech and pharmaceutical manufacturing operations.
Millipore has completed the acquisition of over 90% of the shares of NovAseptic from the company's majority shareholders.
Millipore is in the process of acquiring the remaining shares from the minority shareholders.
Martin Madaus, Millipore's chairman, CEO and president, noted: "NovAseptic brings innovative and differentiated products that our biotech and pharmaceutical customers value highly for manufacturing biologics and for monitoring bio-manufacturing processes.
"There is a great fit strategically and tactically, and we've added exceptional technology and talent to Millipore".
The patented NovaSeptum disposable sampling system is used by biotech and pharmaceutical companies to take fluid samples from their drug manufacturing processes, eliminating the risk of false positives due to biological contaminants.
NovaSeptum has been adopted by a number of pharmaceutical and biotechnology companies, and several new evaluations are in progress.
NovAseptic's other aseptic processing components include high-performance mixers and valves, optimally designed for performance and reliability in stringent drug production environments.
These components enjoy an exceptional quality reputation with customers, says Millipore.
